March 26, 2020
March 12, 2020
U.S. Food and Drug Administration Approves Opdivo® (nivolumab) + Yervoy® (ipilimumab) for Patients with Hepatocellular Carcinoma (HCC) Previously Treated with Sorafenib
-Bristol Myers Squibb Company (NYSE: BMY) today announced that Opdivo (nivolumab) 1 mg/kg plus Yervoy (ipilimumab) 3 mg/kg (injections for intravenous use) was approved... Read More
March 12, 2020
Sutro Biopharma Announces Extension of First Cytokine Derivative Research Program Under Collaboration with Merck
Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design... Read More
March 12, 2020
Thermo Fisher Scientific Signs Agreement with Janssen to Co-Develop Companion Diagnostic for Cancer
Thermo Fisher Scientific announced today it has signed an agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson,... Read More
March 12, 2020
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
Invitae Corporation (NYSE: NVTA), a leading medical genetics company, has announced it has entered into definitive agreements to acquire YouScript, a privately held clinical... Read More
March 3, 2020
Thermo Fisher Scientific to Acquire QIAGEN N.V
WALTHAM, Mass. and VENLO, The Netherlands – March 3, 2020 – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and... Read More
February 13, 2020
Thermo Fisher Scientific Introduces NGS-Based Solution for Expanded Carrier Screening Research
Thermo Fisher Scientific has introduced a new next-generation sequencing (NGS)-based solution that enables reproductive health researchers to more efficiently analyze a broad range of... Read More
February 4, 2020
Bicameral, Bipartisan Group of Lawmakers Form Congressional Personalized Medicine Caucus
The Personalized Medicine Coalition (PMC) today announces its support for a new bicameral, bipartisan Congressional Personalized Medicine Caucus formed by Sens. Tim Scott (R-SC)... Read More
January 22, 2020
Governor Cooper Announces over 460 Jobs in Durham as Eli Lilly and Company Selects North Carolina for Major Pharmaceutical Plant
Eli Lilly and Company (NYSE: LLY), a global healthcare and biopharmaceutical company, will invest over $470 million and create more than 460 new jobs... Read More
January 22, 2020
Quest Diagnostics Acquires Blueprint Genetics to Broaden Access to Actionable Insights for Genetic and Rare Diseases
Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has acquired Blueprint Genetics in an all-cash equity... Read More
January 15, 2020
LabCorp to Adopt Thermo Fisher Scientific’s Ion Torrent Genexus Next-Generation Sequencing System and Pan-Cancer Assay for Use in Oncology Research and Development
LabCorp® (NYSE: LH) announced it will adopt the Ion Torrent Genexus System* and Oncomine Precision Assay* for use in research and development of companion... Read More
January 14, 2020
Dr. Thomas J. Lynch Jr. named new president and director of Fred Hutch
Dr. Thomas J. Lynch Jr. will become Fred Hutchinson Cancer Research Center’s new president and director, the organization announced today. Lynch, a well-known cancer... Read More
January 13, 2020
Thermo Fisher Scientific Opens $90 Million Viral Vector Manufacturing Site in Massachusetts
Thermo Fisher Scientific Inc., the world leader in serving science, officially opened its new $90 million viral vector CDMO (contract development and manufacturing organization)... Read More
January 13, 2020
Roche and Illumina partner to broaden patient access to genomic testing
Roche has announced that it has entered into a 15-year, non-exclusive partnership with Illumina to broaden the adoption of distributable next-generation sequencing (NGS) based... Read More
December 12, 2019
Michael Rivers, Head of Roche Digital Pathology, named president of Digital Pathology Association
Michael Rivers, Vice President, Roche Digital Pathology, has been named president of the Digital Pathology Association (DPA), effective Jan. 1, 2020. The DPA is... Read More
December 12, 2019
Thermo Fisher Scientific to Bring One-Day Genomic Profiling to Hematology Oncology
Clinical researchers who take a traditional sequential approach to analyze myeloid malignancies, a highly heterogeneous group of disorders, face a major hurdle: a laborious... Read More
November 21, 2019
Bristol-Myers Squib and Pfizer Announce, Controlled Trial to Evaluate the Effect of Atrial Fibrillation Screening on Health Outcomes in Older Individuals
The Bristol-Myers Squibb-Pfizer Alliance today announced the initiation of a new randomized, controlled study, GUARD-AF (ReducinG stroke by screening for UndiAgnosed atRial fibrillation in... Read More
November 21, 2019
Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a Leading Biopharma Company
Bristol-Myers Squibb Company (NYSE:BMY) has announced that it has completed its acquisition of Celgene Corporation (NASDAQ:CELG) following the receipt of regulatory approval from all... Read More
November 21, 2019
Massive Bio and The American Sexual Health Association Partner to Increase Patient Access to Cervical Cancer Clinical Trials
Massive Bio, a leader in Artificial Intelligence (AI) based oncology clinical trial enrollment, and The American Sexual Health Association (ASHA), a leader in advancing... Read More
November 21, 2019
Quality Cancer Care Alliance Network (QCCA) Selects Integra Connect as Preferred Population Health Analytics Partner
Integra Connect, the leading provider of technologies and services for value-based specialty care, today announced it has been selected by the Quality Cancer Care... Read More
November 20, 2019
Thermo Fisher Scientific Introduces First Next-Generation Sequencing Platform That Delivers Specimen to Report in a Single Day
Thermo Fisher Scientific announced the launch of its Ion Torrent Genexus System, the first fully integrated, next-generation sequencing (NGS) platform featuring an automated specimen-to-report... Read More
September 9, 2019
Thermo Fisher Scientific Signs Agreement with Lilly Oncology for Companion Diagnostic to be Used with RET Inhibitor
Thermo Fisher Scientific today announced an agreement with Eli Lilly and Company for development of a companion diagnostic that will use the U.S Food... Read More
September 9, 2019
Cardea Bio and Nanosens Innovations look to combine companies
The Board of Directors of Cardea Bio and the Board of Directors of Nanosens Innovations have each authorized the respective companies to proceed with... Read More
September 3, 2019
Thermo Fisher Scientific Announces Collaboration to Develop Advanced Analytical Workflows for Clinical Laboratories
Thermo Fisher Scientific, the world leader in serving science, and Cedars-Sinai, a leading nonprofit academic healthcare organization, have entered into a collaboration to develop... Read More
September 3, 2019
KPMG, Coriell Life Sciences And Thermo Fisher Scientific To Collaborate On Links Between Medications And Genes
KPMG’s Clinical Intelligence (KCI) platform is helping clinicians improve the quality of care by furnishing them with pharmacogenomics data – information about how genes... Read More
Tweets
New post: Italian Researchers Identify New SARS-CoV-2 Gene Variants That Provide Clues to Coronavirus’s Epidemiology https://t.co/wnNDBO8tek, - New post: U.S. Food and Drug Administration Approves Opdivo® (nivolumab) + Yervoy® (ipilimumab) for Patients with H https://t.co/YbpVVTV4V4,
- New post: Sutro Biopharma Announces Extension of First Cytokine Derivative Research Program Under Collaboration https://t.co/KIHw86agbC,